Skip to Content

Natpara Approval History

  • FDA approved: Yes (First approved January 23rd, 2015)
  • Brand name: Natpara
  • Generic name: parathyroid hormone
  • Dosage form: Injection
  • Company: NPS Pharmaceuticals, Inc.
  • Treatment for: Hypoparathyroidism

Natpara (parathyroid hormone) is recombinant human parathyroid hormone 1-84 indicated to control hypocalcemia in patients with hypoparathyroidism.

Development History and FDA Approval Process for Natpara

Jan 23, 2015Approval FDA Approves Natpara (parathyroid hormone) for Hypocalcemia in Patients with Hypoparathyroidism
Sep  5, 2012NPS Pharmaceuticals Expects to File Natpara BLA in Mid-2013

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.